Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
about
Neurocognitive sequelae of childhood cancers and their treatmentEstimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastomaDietary essential fatty acids and gender-specific behavioral responses in cranially irradiated ratsFunctional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment.Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complicationsCarboplatin-based primary chemotherapy for infants and young children with CNS tumorsImpact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology GroupExamination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastomaNeuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiationPediatric low-grade gliomas.Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumorComparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastomaInhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in MedulloblastomaUsing lithium as a neuroprotective agent in patients with cancerOverview: chemotherapy for retinoblastoma: an expanding area of clinical research.The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validityRadiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts.Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies.Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancerTemperament and social behavior in pediatric brain tumor survivors and comparison peers.Atypical white matter volume development in children following craniospinal irradiationRemediation of attention deficits in children: a focus on childhood cancer, traumatic brain injury and attention deficit disorder.Neurocognitive outcomes in survivors of childhood cancer.Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young childrenClinical Implications of Psychosocial Factors on Pediatric External Fixation Treatment and Recommendations.Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973-2010).Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.The clinical case for proton beam therapy.Radiation dose-volume effects in the brain.Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.Childhood brain tumors: accomplishments and ongoing challenges.Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastomaNeurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual modelEarly Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects.Chemotherapy for malignant brain tumors of childhood.Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.Survivors of pediatric posterior fossa tumors: cognitive outcome, intervention, and risk-based care.
P2860
Q28240816-2D411943-B55E-4587-906B-DF30423D0911Q28267052-23B7192C-196E-4B56-846B-1AC5A002A05DQ30490017-7DBCECCD-F625-434B-BE1B-2C17D22B8776Q30676878-EDC9D831-71F0-4910-9598-7F3762AB9572Q33315598-B9B3E4DC-CBBE-4B0B-AEE3-638F1C95716BQ33384747-451EFFF0-5E9A-451D-8F6A-2AC685C025B0Q33442381-35602B13-D9E9-4A70-BA5D-87AF8D955204Q33863188-D364094C-1938-45FE-869C-571221E04652Q33894464-DEACF3F8-A444-49FD-9CA0-776325A917EFQ34024674-9EC03C63-011B-4A82-8C00-72FC49AB9784Q34051368-0C9156CB-699F-46FA-8E7B-0ED2D3E5B79CQ34316845-02EAB574-80A1-473B-ADAC-3BEAA01E33CDQ34350198-C52C29ED-93BC-4458-BC73-934423D230AFQ34398276-6210EA5A-8501-4A82-A60A-7D1F52C99C21Q34465844-0F823331-8100-4EC0-B139-A20E0C698D5EQ34621002-08DF092F-D01E-48F6-9BAF-C371CD67E6CAQ34714835-FA93BBE3-3E7F-411A-ACFE-D566A6B44060Q34737158-D4895B6A-1A29-4A29-BE4D-FFBA66F5981CQ34992530-983FF71D-224F-45E8-9106-2242A7FC0122Q35047116-358515D6-EFCF-4308-AB49-088C019F39B6Q35196802-AD20BE81-A000-408E-B643-B4C632C813B5Q35799871-55B590C4-BEB7-4A45-A4BD-C61C296B4298Q35809625-CF02301F-5226-49F9-8B7C-692088D8959DQ35990012-8627731D-1479-4E7C-A0EC-A3D4A6B5DC44Q36028391-226D9EF6-A8B3-4A7C-B66B-7E7944CA5E53Q36037825-923B4E9C-9884-4F8F-9952-45D7663A7797Q36093313-33515852-42D9-4AAC-A243-3CFA241CA699Q36344727-D9848280-50DB-4BFE-A382-1A34B87213A1Q36547835-37EAEDCB-0F0C-4CED-8235-8342399D00B7Q36560171-4E7E5B6D-4D80-406C-AE2B-81793E159EE4Q36627160-8F50ACC7-5495-4322-8951-F30199DC9F90Q36737527-4F098DBD-19C8-4240-8E0A-3DC23DDFC800Q36908335-3216CC3B-321D-48CC-B527-93CA04CCE3E7Q36950640-3CCC25BF-650F-4FCA-B23D-A3B7949B6C71Q37065670-20C13C70-59FF-408F-B34D-0858F207076BQ37113836-635CF391-0C23-4109-BC96-C8B4ACA1EAE6Q37167767-0FAFFB6C-3702-4B1B-BD93-2BDB7B0D53CCQ37226508-A509A92D-4DE2-470F-844B-2891F4BDCBDFQ37246499-8DFD6176-B32E-4555-9DDE-16A4922CDAE3Q37288153-BC429C83-FDCB-433B-BAD1-229D13645EB2
P2860
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@en
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@nl
type
label
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@en
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@nl
prefLabel
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@en
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@nl
P2093
P1476
Neuropsychologic functioning o ...... ediatric Oncology Group study.
@en
P2093
F D Armstrong
J L Kepner
P R Thomas
R K Mulhern
P304
P356
10.1200/JCO.1998.16.5.1723
P407
P577
1998-05-01T00:00:00Z